Here are five notes:
1. In November 2015, the FDA ordered Custom Ultrasonics to recall all of its Automated Endoscope Reprocessors.
2. Later that same month, Custom Ultrasonics submitted a recall strategy to the FDA. However, the FDA found it inadequate.
3. Since then, the company has made no additional proposals to the FDA to recall its AERs.
4. In January 2016, the FDA sent a letter to Custom Ultrasonics reinforcing the terms of the recall order and requiring Custom Ultrasonics to remove its AERs from the market.
5. Thus, the FDA restated that organizations using the company’s AERs transition to other reprocessing methods.
More articles on GI/endoscopy:
GI physician leader to know: Dr. Shivagi Kothari of University of Rochester Medical Center
EndoChoice receives average price target of $19.67: 4 points
URMC GI experts to host advanced endoscopy course for nurses, mid-level providers: 4 notes
